Circulating Markers of Inflammation and Endothelial Dysfunction Associated With Increased Progression of Internal

Hediyeh Baradaran1, Adlin Pinheiro2,3, Emelia J Benjamin3,4,5

  • 1Department of Radiology and Imaging Sciences University of Utah Salt Lake City UT USA.

Insights

Markers of inflammation and endothelial dysfunction are linked to increased carotid artery intima-media thickness (CIMT) progression. This study in the Framingham Heart Study cohort highlights key inflammatory markers associated with subclinical atherosclerosis.

Area of Science:

  • Cardiovascular Science
  • Biomarkers
  • Atherosclerosis Research

Background:

  • Subclinical atherosclerosis, indicated by carotid artery intima-media thickness (CIMT), is linked to cardiovascular and cerebrovascular diseases.
  • The association between circulating inflammatory markers and CIMT progression remains unclear.
  • This study investigates the relationship between inflammation, endothelial dysfunction markers, and CIMT progression in the Framingham Heart Study (FHS) cohort.

Purpose of the Study:

  • To determine if circulating markers of inflammation and endothelial dysfunction are associated with the progression of internal carotid artery intima-media thickness (ICIMT).
  • To examine the cross-sectional association between these markers and ICIMT.
  • To adjust for established vascular risk factors and baseline ICIMT in the analysis.

Main Methods:

  • Utilized multivariable linear regression to analyze data from 2264 participants in the Framingham Heart Study.
  • Assessed the association between specific circulating inflammatory markers and both cross-sectional ICIMT and ICIMT progression (rate of change in mm/y).
  • Primary analyses adjusted for age, sex, hypertension, diabetes, APOE4, BMI, and smoking; secondary analyses also adjusted for baseline ICIMT.

Main Results:

  • Higher baseline levels of C-reactive protein, lipoprotein-associated phospholipase A activity, and isoprostanes were significantly associated with increased ICIMT progression (p<0.05).
  • Cross-sectional analysis revealed significant associations between higher levels of interleukin-6, osteoprotegerin, and P-selectin with higher ICIMT.
  • The findings were adjusted for key vascular risk factors and baseline CIMT measurements.

Conclusions:

  • Specific circulating markers of inflammation and endothelial dysfunction are significantly associated with increased ICIMT.
  • These inflammatory markers are implicated in the progression of carotid atherosclerosis.
  • The results contribute to understanding the inflammatory pathways involved in cardiovascular disease development.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
295